CONTACT INFORMATION http://www.loyola.org
Scott Smith
M.D.,Ph.D., FACP
  • Associate Professor
  • Hematology/Oncology
Specialties
Leukemia, Non-Hodgkin's Lymphoma, Refractory Lymphoma, Relapsed Lymphoma, Bone Marrow Disorders
Board Certifications
  • Hematology - Subspecialty Cert: AM Board of Internal Medicine
  • Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine
Publications

Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacyGopal,A. K.; Bartlett,N. L.; Forero-Torres,A.; Younes,A.; Chen,R.; Friedberg,J. W.; Matous,J. V.; Shustov,A. R.; Smith,S. E.; Zain,J.; O'Meara,M. M.; Fanale,M. A.Leukemia & lymphoma 2014 ; ( ):

Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trialJain,N.; Curran,E.; Iyengar,N. M.; Diaz-Flores,E.; Kunnavakkam,R.; Popplewell,L.; Kirschbaum,M. H.; Karrison,T.; Erba,H. P.; Green,M.; Poire,X.; Koval,G.; Shannon,K.; Reddy,P. L.; Joseph,L.; Atallah,E. L.; Dy,P.; Thomas,S. P.; Smith,S. E.; Doyle,L. A.; Stadler,W. M.; Larson,R. A.; Stock,W.; Odenike,O.Clinical cancer research : an official journal of the American Association for Cancer Research 2014 ;20(2):490-498

Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual diseaseSobol,U.; Rodriguez,T.; Smith,S.; Go,A.; Vimr,R.; Parthasarathy,M.; Guo,R.; Stiff,P.Leukemia & lymphoma 2014 ;55(6):1281-1287

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignanciesBartlett,N. L.; Chen,R.; Fanale,M. A.; Brice,P.; Gopal,A.; Smith,S. E.; Advani,R.; Matous,J. V.; Ramchandren,R.; Rosenblatt,J. D.; Huebner,D.; Levine,P.; Grove,L.; Forero-Torres,A.Journal of hematology & oncology 2014 ;7( ):24-8722-7-24

Impact of induction regimen and stem cell transplantation on outcomes in patients with double hit lymphoma: a large multicenter retrospective analysisPetrich,A. M.; Gandhi,M.; Jovanovic,B.; Castillo,J. J.; Rajguru,S.; Yang,D. T.; Shah,K. A.; Whyman,J. D.; Lansigan,F.; Hernandez-Ilizaliturri,F. J.; Lee,L. X.; Barta,S. K.; Melinamani,S.; Karmali,R.; Adeimy,C.; Smith,S.; Dalal,N.; Nabhan,C.; Peace,D.; Vose,J.; Evens,A. M.; Shah,N.; Fenske,T.; Zelenetz,A. D.; Landsburg,D. J.; Howlett,C.; Mato,A.; Jaglal,M.; Chavez,J. C.; Tsai,J. P.; Reddy,N.; Li,S.; Handler,C.; Flowers,C. R.; Cohen,J. B.; Blum,K. A.; Song,K.; Sun,H. L.; Press,O.; Cassaday,R.; Jaso,J.; Medeiros,L. J.; Sohani,A. R.; Abramson,J. S.Blood 2014 ; ( ):

Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignanciesHan,T. H.; Chen,R.; Advani,R.; Berryman,R. B.; Smith,S. E.; Forero-Torres,A.; Rosenblatt,J. D.; Smith,M. R.; Zain,J.; Hunder,N. N.; Engert,A.CANCER CHEMOTHERAPY AND PHARMACOLOGY 2013 ;72(1):241-249

Marginal zone lymphoma of the thoracic dura causing spinal cord compressionDey,M.; Daniel,S.; Wong,R. H.; Smith,S. M.; Yamini,B.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2013 ;20(1):171-173

Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimensStiff,P. J.; Fox-Geiman,M. P.; Kiley,K.; Rychlik,K.; Parthasarathy,M.; Fletcher-Gonzalez,D.; Porter,N.; Go,A.; Smith,S. E.; Rodriguez,T. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013 ;19(1):49-55.e1

High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemiaO'Brien,S.; Schiller,G.; Lister,J.; Damon,L.; Goldberg,S.; Aulitzky,W.; Ben-Yehuda,D.; Stock,W.; Coutre,S.; Douer,D.; Heffner,L. T.; Larson,M.; Seiter,K.; Smith,S.; Assouline,S.; Kuriakose,P.; Maness,L.; Nagler,A.; Rowe,J.; Schaich,M.; Shpilberg,O.; Yee,K.; Schmieder,G.; Silverman,J. A.; Thomas,D.; Deitcher,S. R.; Kantarjian,H.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 ;31(6):676-683

Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantationGopal,A. K.; Ramchandren,R.; O'Connor,O. A.; Berryman,R. B.; Advani,R. H.; Chen,R.; Smith,S. E.; Cooper,M.; Rothe,A.; Matous,J. V.; Grove,L. E.; Zain,J.Blood 2012 ;120(3):560-568

TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomesChoi,S. W.; Stiff,P.; Cooke,K.; Ferrara,J. L.; Braun,T.; Kitko,C.; Reddy,P.; Yanik,G.; Mineishi,S.; Paczesny,S.; Hanauer,D.; Pawarode,A.; Peres,E.; Rodriguez,T.; Smith,S.; Levine,J. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012 ;18(10):1525-1532

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern eraEvens,A. M.; Helenowski,I.; Ramsdale,E.; Nabhan,C.; Karmali,R.; Hanson,B.; Parsons,B.; Smith,S.; Larsen,A.; McKoy,J. M.; Jovanovic,B.; Gregory,S.; Gordon,L. I.; Smith,S. M.Blood 2012 ;119(3):692-695

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern eraEvens,A. M.; Helenowski,I.; Ramsdale,E.; Nabhan,C.; Karmali,R.; Hanson,B.; Parsons,B.; Smith,S.; Larsen,A.; McKoy,J. M.; Jovanovic,B.; Gregory,S.; Gordon,L. I.; Smith,S. M.Blood 2012 ;119(3):692-695

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphomaYounes,A.; Gopal,A. K.; Smith,S. E.; Ansell,S. M.; Rosenblatt,J. D.; Savage,K. J.; Ramchandren,R.; Bartlett,N. L.; Cheson,B. D.; de Vos,S.; Forero-Torres,A.; Moskowitz,C. H.; Connors,J. M.; Engert,A.; Larsen,E. K.; Kennedy,D. A.; Sievers,E. L.; Chen,R.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 ;30(18):2183-2189

Spontaneous regression of follicular dendritic cell sarcomaCaces,D. B.; Daniel,S.; Paredes-Tejada,J. M.; Smith,S.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 ;30(3):e24-6

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)Raza,A.; Galili,N.; Mulford,D.; Smith,S. E.; Brown,G. L.; Steensma,D. P.; Lyons,R. M.; Boccia,R.; Sekeres,M. A.; Garcia-Manero,G.; Mesa,R. A.Journal of hematology & oncology 2012 ;5( ):18-8722-5-18

A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndromeRaza,A.; Galili,N.; Smith,S. E.; Godwin,J.; Boccia,R. V.; Myint,H.; Mahadevan,D.; Mulford,D.; Rarick,M.; Brown,G. L.; Schaar,D.; Faderl,S.; Komrokji,R. S.; List,A. F.; Sekeres,M.Cancer 2012 ;118(8):2138-2147

Analysis of very elderly (>/=80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcomeNabhan,C.; Smith,S. M.; Helenowski,I.; Ramsdale,E.; Parsons,B.; Karmali,R.; Feliciano,J.; Hanson,B.; Smith,S.; McKoy,J.; Larsen,A.; Hantel,A.; Gregory,S.; Evens,A. M.British journal of haematology 2012 ;156(2):196-204

Analysis of very elderly (>/=80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcomeNabhan,C.; Smith,S. M.; Helenowski,I.; Ramsdale,E.; Parsons,B.; Karmali,R.; Feliciano,J.; Hanson,B.; Smith,S.; McKoy,J.; Larsen,A.; Hantel,A.; Gregory,S.; Evens,A. M.British journal of haematology 2012 ;156(2):196-204

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSmith,S. M.; van Besien,K.; Karrison,T.; Dancey,J.; McLaughlin,P.; Younes,A.; Smith,S.; Stiff,P.; Lester,E.; Modi,S.; Doyle,L. A.; Vokes,E. E.; Pro,B.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(31):4740-4746

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSmith,S. M.; van Besien,K.; Karrison,T.; Dancey,J.; McLaughlin,P.; Younes,A.; Smith,S.; Stiff,P.; Lester,E.; Modi,S.; Doyle,L. A.; Vokes,E. E.; Pro,B.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(31):4740-4746

Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation.Gerds,A.; Fox-Geiman,M.; Dawravoo,K.; Rodriguez,T.; Toor,A.; Smith,S.; Kiley,K.; Fletcher-Gonzalez,D.; Hicks,C.; Stiff,P.Biology of Blood & Marrow Transplantation 2010 ;16(5):678-685

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern eraEvens,A. M.; David,K. A.; Helenowski,I.; Nelson,B.; Kaufman,D.; Kircher,S. M.; Gimelfarb,A.; Hattersley,E.; Mauro,L. A.; Jovanovic,B.; Chadburn,A.; Stiff,P.; Winter,J. N.; Mehta,J.; Van Besien,K.; Gregory,S.; Gordon,L. I.; Shammo,J. M.; Smith,S. E.; Smith,S. M.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(6):1038-1046

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern eraEvens,A. M.; David,K. A.; Helenowski,I.; Nelson,B.; Kaufman,D.; Kircher,S. M.; Gimelfarb,A.; Hattersley,E.; Mauro,L. A.; Jovanovic,B.; Chadburn,A.; Stiff,P.; Winter,J. N.; Mehta,J.; Van Besien,K.; Gregory,S.; Gordon,L. I.; Shammo,J. M.; Smith,S. E.; Smith,S. M.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(6):1038-1046

The impact of pharmacotherapy on depression and quality of life in patients undergoing a bone marrow transplant (BMT).Mumby,P. B.; Garcia,C.; Trivedi-Purohit,R.; Gourvitz,R.; Rychlik,K.; Rodriguez,T.; Smith,S. E.; Toor,A. A.; Rao,M.; Stiff,P. J.ASCO Meeting Abstracts 2010 ;28(15_suppl):9132

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndromeRaza,A.; Galili,N.; Smith,S.; Godwin,J.; Lancet,J.; Melchert,M.; Jones,M.; Keck,J. G.; Meng,L.; Brown,G. L.; List,A.Blood 2009 ;113(26):6533-6540

A single-institution experience with the AneuRx Stent Graft for endovascular repair of abdominal aortic aneurysm.Smith,S.; Mountcastle,S.; Burridge,A.; Dodson,T. F.; Salam,A. A.; Kasirajan,K.; Milner,R.; Veeraswamy,R.; Chaikof,E. L.Annals of Vascular Surgery 2008 ;22(2):221-226

The Curriculum for the Hospitalized Aging Medical Patient program: a collaborative faculty development program for hospitalists, general internists, and geriatricians.Podrazik,P. M.; Levine,S.; Smith,S.; Scott,D.; Dubeau,C. E.; Baron,A.; Whelan,C.; Johnson,J.; Cook,S.; Arora,V.; Meltzer,D.; Sachs,G.Journal of Hospital Medicine (Online) 2008 ;3(5):384-393

Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialNand,S.; Godwin,J.; Smith,S.; Barton,K.; Michaelis,L.; Alkan,S.; Veerappan,R.; Rychlik,K.; Germano,E.; Stiff,P.Leukemia & lymphoma 2008 ;49(11):2141-2147

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCTToor,A.; Rodriguez,T.; Bauml,M.; Mathews,H.; Shanti,S.; Senitzer,D.; Kini,A.; Norton,J.; Parthasarathy,M.; Mohideen,N.; Petrowsky,C.; Bonilla,B.; Smith,S.; Stiff,P.Bone marrow transplantation 2008 ;42(11):723-731

Volvox species in the Pap test of a 24-year-old female.Vasquez,J. B.; Smith,S. V.; Thomas,R.; Yong,S. L.; Wojcik,E. M.Diagnostic cytopathology 2008 ;36(8):574-575

Sonographic appearance of ruptured ovarian cyst in the neonatal period.Gallagher,T. A.; Lim-Dunham,J. E.; Vade,A.; Smith,S.; Salhadar,A.; Ward,K. A.Journal of Clinical Ultrasound 2008 ;36(1):53-55

Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.Palmer,S. M.; Burch,L. H.; Mir,S.; Smith,S. R.; Kuo,P. C.; Herczyk,W. F.; Reinsmoen,N. L.; Schwartz,D. A.Clinical transplantation 2006 ;20(1):30-36

The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failureSmith,S. E.; Toor,A.; Rodriguez,T.; Stiff,P.Comprehensive therapy 2006 ;32(3):172-175

Megakaryoblastic leukemia with involvement of the pleural fluid.Farray,D.; Al-Masri,H.; Hattersley,E.; Smith,S. E.American Journal of Hematology 2005 ;79(3):238-239

Obesity predicts increased overall complications following pancreas transplantation.Hanish,S. I.; Petersen,R. P.; Collins,B. H.; Tuttle-Newhall,J.; Marroquin,C. E.; Kuo,P. C.; Butterly,D. W.; Smith,S. R.; Desai,D. M.Transplantation proceedings 2005 ;37(8):3564-3566

Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group.Smith,S. C.,Jr.; Clark,L. T.; Daniels,S. R.; Kumanyika,S. K.; Ofili,E.; Quinones,M. A.; Sanchez,E. J.; Saunders,E.; Tiukinhoy,S. D.Circulation 2005 ;111(10):e134-9

15th Annual Spring Brain Conference, March 10-13, 2004, summary report.Anstrom,K.; Bergles,D.; Bradley,K.; Cao,Y.; Cestnick,L.; Lee,S.; Piedras-Renteria,E. S.; Savoie,K.; Smith,S. M.Somatosensory & motor research 2004 ;21(2):137-143

The signal from the initiation of meiotic recombination to the first division of meiosisMalone,R. E.; Haring,S. J.; Foreman,K. E.; Pansegrau,M. L.; Smith,S. M.; Houdek,D. R.; Carpp,L.; Shah,B.; Lee,K. E.Eukaryotic cell 2004 ;3(3):598-609

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.Rocha,P. N.; Butterly,D. W.; Greenberg,A.; Reddan,D. N.; Tuttle-Newhall,J.; Collins,B. H.; Kuo,P. C.; Reinsmoen,N.; Fields,T.; Howell,D. N.; Smith,S. R.Transplantation 2003 ;75(9):1490-1495

Acute myeloid leukemia in the older patientGodwin,J. E.; Smith,S. E.Critical Reviews in Oncology-Hematology 2003 ;48(Suppl):S17-26

Education
Medical School
  • Wayne State University School of Medicine
Residency
  • Loyola University Medical Center, Internal Medicine: General
Fellowship
  • Loyola University Medical Center, Hematology/Oncology
Interests
  • Fly Fishing
  • Mountain Biking
  • Hiking
  • Reading
  • Golf